A novel combination of insulin degludec and liraglutide, IDegLira, enables patients with Type 2 diabetes to reach target glycaemic control faster than its individual components alone Article

Web of Science: 000351177500198
Industry Collaboration International Collaboration

Cited authors

  • Vora, J.; Vilsboll, T.; Jarlov, H.; Kvist, K.; Blonde, L.

Authors

Publication date

  • 2015

Published in

International Standard Serial Number (ISSN)

  • 0742-3071

Start page

  • 75

End page

  • 76

Volume

  • 32